Literature DB >> 29333138

Highlight report: Monitoring cytochrome P450 activities in living hepatocytes.

Ahmed Ghallab1.   

Abstract

Entities:  

Year:  2017        PMID: 29333138      PMCID: PMC5763087          DOI: 10.17179/excli2017-1039

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Recently, Jannick Theobald and Xinlai Cheng from Heidelberg University published a methods' paper how to monitor cytochrome P450 (CYP) activities in living hepatocytes (Theobald et al., 2017[15]). For this purpose, the authors used substrates that are metabolized by CYP enzymes thereby forming highly fluorescent leaving groups that were quantified by a plate reader. This technique allows repeated real-time measurements of cultivated hepatocytes over extincted time periods (Theobald et al., 2017[15]). The monitoring technique was validated by the use of CYP inducers and was applied to characterize differentiating HepaRG cells. The authors conclude that the fluorescence-based assay can easily be used as a tool to characterize hepatocyte in vitro systems. Hepatotoxicity still represents a major challenge in drug development (Leist et al., 2017[8]; Schenk et al., 2017[12]; Reif et al., 2017[11]; Jansen et al., 2017[6]; Crespo Yanguas et al., 2016[3]; Stöber, 2015[13], 2016[14]; Yanguas et al., 2016[19]; Braeuning and Schwarz, 2016[2]). Currently, much effort is invested to develop improved hepatocyte in vitro systems (Godoy et al., 2013[5]; Ramboer et al., 2015[10]; Verhulst et al., 2015[18]; Pfeiffer et al., 2015[9]; Kim et al., 2015[7]) and in silico techniques (Ghallab et al., 2016[4]; Bartl et al., 2015[1]; Vartak et al., 2016[17]; Thiel et al., 2015[16]). The technique presented by Theobald and colleagues can easily be integrated into in vitro systems and should therefore facilitate characterization of cultivated hepatocytes.
  19 in total

1.  A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation.

Authors:  Christoph Thiel; Sebastian Schneckener; Markus Krauss; Ahmed Ghallab; Ute Hofmann; Tobias Kanacher; Sebastian Zellmer; Rolf Gebhardt; Jan G Hengstler; Lars Kuepfer
Journal:  J Pharm Sci       Date:  2014-11-12       Impact factor: 3.534

Review 2.  The ascending pathophysiology of cholestatic liver disease.

Authors:  Peter L M Jansen; Ahmed Ghallab; Nachiket Vartak; Raymond Reif; Frank G Schaap; Jochen Hampe; Jan G Hengstler
Journal:  Hepatology       Date:  2017-02       Impact factor: 17.425

Review 3.  Adverse outcome pathways: opportunities, limitations and open questions.

Authors:  Marcel Leist; Ahmed Ghallab; Rabea Graepel; Rosemarie Marchan; Reham Hassan; Susanne Hougaard Bennekou; Alice Limonciel; Mathieu Vinken; Stefan Schildknecht; Tanja Waldmann; Erik Danen; Ben van Ravenzwaay; Hennicke Kamp; Iain Gardner; Patricio Godoy; Frederic Y Bois; Albert Braeuning; Raymond Reif; Franz Oesch; Dirk Drasdo; Stefan Höhme; Michael Schwarz; Thomas Hartung; Thomas Braunbeck; Joost Beltman; Harry Vrieling; Ferran Sanz; Anna Forsby; Domenico Gadaleta; Ciarán Fisher; Jens Kelm; David Fluri; Gerhard Ecker; Barbara Zdrazil; Andrea Terron; Paul Jennings; Bart van der Burg; Steven Dooley; Annemarie H Meijer; Egon Willighagen; Marvin Martens; Chris Evelo; Enrico Mombelli; Olivier Taboureau; Alberto Mantovani; Barry Hardy; Bjorn Koch; Sylvia Escher; Christoph van Thriel; Cristina Cadenas; D Kroese; Bob van de Water; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2017-10-19       Impact factor: 5.153

4.  3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis.

Authors:  Jin-Young Kim; David A Fluri; Rosemarie Marchan; Kurt Boonen; Soumyaranjan Mohanty; Prateek Singh; Seddik Hammad; Bart Landuyt; Jan G Hengstler; Jens M Kelm; Andreas Hierlemann; Olivier Frey
Journal:  J Biotechnol       Date:  2015-01-12       Impact factor: 3.307

5.  Drug-induced mitochondrial impairment in liver cells.

Authors:  Regina Stöber
Journal:  EXCLI J       Date:  2015-12-22       Impact factor: 4.068

6.  Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage.

Authors:  Arne Schenk; Ahmed Ghallab; Ute Hofmann; Reham Hassan; Michael Schwarz; Andreas Schuppert; Lars Ole Schwen; Albert Braeuning; Donato Teutonico; Jan G Hengstler; Lars Kuepfer
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

7.  Effects of Trichostatin A on drug uptake transporters in primary rat hepatocyte cultures.

Authors:  Eva Ramboer; Vera Rogiers; Tamara Vanhaecke; Mathieu Vinken
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

Review 8.  Advances in hepatic stem/progenitor cell biology.

Authors:  Stefaan Verhulst; Jan Best; Leo A van Grunsven; Laurent Dollé
Journal:  EXCLI J       Date:  2015-01-06       Impact factor: 4.068

9.  Cholestasis-induced adaptive remodeling of interlobular bile ducts.

Authors:  Nachiket Vartak; Amruta Damle-Vartak; Beate Richter; Olaf Dirsch; Uta Dahmen; Seddik Hammad; Jan G Hengstler
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

Review 10.  Connexins and pannexins in liver damage.

Authors:  Sara Crespo Yanguas; Joost Willebrords; Michaël Maes; Tereza Cristina da Silva; Isabel Veloso Alves Pereira; Bruno Cogliati; Maria Lucia Zaidan Dagli; Mathieu Vinken
Journal:  EXCLI J       Date:  2016-02-25       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.